Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations (Q44073432)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations |
scientific article |
Statements
1 reference
Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations (English)
1 reference
Tomoko Kita
1 reference
Toshiyuki Sakaeda
1 reference
Nobuo Aoyama
1 reference
Toshiyuki Sakai
1 reference
Yuko Kawahara
1 reference
Masato Kasuga
1 reference
Katsuhiko Okumura
1 reference
1 July 2002
1 reference
1 reference
Identifiers
1 reference